AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs
PositiveFinancial Markets

AbbVie has raised its annual profit forecast, reflecting strong demand for its newer immunology drugs. This is significant as it highlights the company's ability to adapt and thrive in a competitive market, reassuring investors about its growth potential and the effectiveness of its innovative treatments.
— Curated by the World Pulse Now AI Editorial System







